Planet Labs PBC (PL)


Planet Labs PBC is a San Francisco-based company that develops and operates satellite constellations and related geospatial data services. Founded in 2010 and listed on the NYSE as common stock, the company designs, builds, launches, and operates satellites intended to deliver frequent Earth imagery and analysis through its online platform. Its offerings include SuperDove satellites for daily global imaging at up to 3.5-meter ground sampling distance, SkySat and Pelican satellites for higher-resolution tasking with imagery processed to as fine as 50 centimeters, and the Tanager hyperspectral satellite for full-spectrum observations across visible and shortwave infrared bands.

Planet Labs also provides an Earth observation platform that allows customers and partners to search, analyze, and use proprietary data through APIs and browser-based tools. In addition, it offers satellite services such as customer-owned satellite design and manufacturing, mission engineering, launch support, ground station infrastructure, operations, maintenance, and dedicated imaging capacity. Its customers include agriculture, mapping, energy, forestry, finance, insurance, and government organizations, in the United States and internationally.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-PL
$11.34
-51.0% Downside
Expensive
$40.10
73.3% Upside
Bargain
Fair
0.0%
September 14, 2026
-22.1x
18.6x
24.6x
7.894 B
8.01 B
5.7%
82.7%
4.5
-12.5%
Valuation • Fair Value

Planet Labs PBC (NYSE-PL) Fair Value by Valuation Model

Compare the primary fair value estimate for Planet Labs PBC (NYSE-PL) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$11.34

Estimated downside of 51.0% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$10.51

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$12.18

Comparable-company valuation reference.

Analyst Price Target

$40.10

Analysts imply upside of 73.3%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Planet Labs PBC (NYSE-PL) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Planet Labs PBC (NYSE-PL)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

335.6 M

Current operating scale indicator.

Revenue Forecast

435.4 M

Forward revenue estimate.

EBITDA

-51.719 M

Current operating profitability reference.

EBITDA Forecast

8.754 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Planet Labs PBC (NYSE-PL) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Planet Labs PBC (NYSE-PL)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

3

Weak quality score that deserves closer review.

Beneish M-Score

-4.96

No elevated caution signal from this screen.

Altman Z-Score

4.5

Relatively strong balance-sheet zone.

FCF / Net Income

-12.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Planet Labs PBC (NYSE-PL). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Planet Labs PBC (NYSE-PL)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

September 14, 2026

Days to Earnings

55

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Planet Labs PBC (NYSE-PL), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Planet Labs PBC (NYSE-PL) Stock Forecast & Technical Outlook

Review Planet Labs PBC (NYSE-PL) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Planet Labs PBC (NYSE-PL) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Buy

The 1-hour technical read for Planet Labs PBC (NYSE-PL) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Planet Labs PBC (NYSE-PL) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Planet Labs PBC (NYSE-PL) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Planet Labs PBC (NYSE-PL) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Planet Labs PBC (NYSE-PL)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Planet Labs PBC (NYSE-PL) has a Buy consensus, with 6 buy, 3 hold and 1 sell recommendations in the current data set.

Buy 6
Hold 3
Sell 1
FAQ Fast Investor Answers

Planet Labs PBC (NYSE-PL) Stock FAQ

Quick answers about Planet Labs PBC (NYSE-PL) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$11.34
Estimated downside 51.0%
Valuation Rating
Overvalued
Estimated downside of 51.0%
Analyst Target
$40.10
Implied upside 73.3%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Planet Labs PBC (NYSE-PL) is $11.34. This implies an estimated downside of 51.0% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 51.0% versus the current market price.

The available analyst price target for Planet Labs PBC (NYSE-PL) is $40.10. The analyst target implies estimated upside of 73.3%.

The current financial health read for Planet Labs PBC (NYSE-PL) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Planet Labs PBC (NYSE-PL) is September 14, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Planet Labs PBC (NYSE-PL) is -22.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Planet Labs PBC is 7.894 B.

The current enterprise value listed for Planet Labs PBC is 8.01 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Planet Labs PBC is NYSE-PL, and the stock is listed on NYSE.

Planet Labs PBC (NYSE-PL) is listed on NYSE.

The current debt-to-total-capital ratio listed for Planet Labs PBC is 5.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Planet Labs PBC is 82.7%. Free float helps investors understand how much of the share base is available for public trading.